CIPLA Cipla Ltd US FDA Inspections Announcement 2023 - US FDA Inspection Update Cipla Ltd. has received the EIR from the USFDA stating that the inspection of their InvaGen manufacturing facility has been classified as Voluntary Action Indicated (VAI)..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Cipla Ltd